Biotech Values

[DewDiligence]

MYOV hires new CEO:

https://www.globenewswire.com/news-release/2021/01/04/2152496/0/en/Myovant-Sciences-Appoints-Industry-Veteran-David-Marek-as-Chief-Executive-Officer.html

Mr. Marek is a veteran biopharmaceutical executive with over 30 years of experience in the industry. He brings to Myovant the commercial expertise of a seasoned pharmaceutical executive, the strategic prowess from leading one of the world’s most successful healthcare advertising agencies, as well as the consumer and digital marketing know-how from one of the most popular health information portals, WebMD. Mr. Marek joins Myovant from Axsome Therapeutics where he was chief commercial officer responsible for building out commercial capabilities in preparation for multiple expected launches.

The PR praises outgoing CEO, Lynn Seeley, but it says nothing about her reason for leaving or where she is going.